Benzinga's Top Upgrades, Downgrades For January 24, 2017

By: via Benzinga
Top Upgrades Analysts at Citigroup upgraded Calithera Biosciences Inc (NASDAQ: CALA) from Sell to Neutral. Calithera ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.